These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 21718391
1. Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI. Garming-Legert K, Remberger M, Ringdén O, Hassan M, Dahllöf G. Oral Dis; 2011 Oct; 17(7):670-6. PubMed ID: 21718391 [Abstract] [Full Text] [Related]
2. Salivary secretion in children after fractionated or single-dose TBI. Garming Legert K, Remberger M, Ringdèn O, Heimdahl A, Dahllöf G. Bone Marrow Transplant; 2012 Mar; 47(3):404-10. PubMed ID: 21552301 [Abstract] [Full Text] [Related]
3. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients. Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Kabisch H, Jaburg N, Löliger C, Krüll A, Zander AR. Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663 [Abstract] [Full Text] [Related]
4. Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan. Dahllöf G, Wondimu B, Barr-Agholme M, Garming-Legert K, Remberger M, Ringdén O. Oral Oncol; 2011 Sep; 47(9):915-9. PubMed ID: 21784697 [Abstract] [Full Text] [Related]
5. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia]. Liu QF, Sun J, Xu D, Zhang Y, Fan ZP, Wei YQ, Meng FY, Zhou SY. Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779 [Abstract] [Full Text] [Related]
6. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W. Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [Abstract] [Full Text] [Related]
7. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study. Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S. Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124 [Abstract] [Full Text] [Related]
9. Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study. Sisler IY, Koehler E, Koyama T, Domm JA, Ryan R, Levine JE, Pulsipher MA, Haut PR, Schultz KR, Taylor DS, Frangoul HA. Biol Blood Marrow Transplant; 2009 Dec; 15(12):1620-7. PubMed ID: 19896086 [Abstract] [Full Text] [Related]
10. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience. Hamidieh A, Kargar M, Jahani M, Alimoghaddam K, Bahar B, Mousavi SA, Iravani M, Jalali A, Jalili M, Ghavamzadeh A. J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385 [Abstract] [Full Text] [Related]
11. [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia]. Tong XZ, Xu DR, Zou WY, Li J, Luo SK, Peng AH, Zhang GC, Zheng D. Ai Zheng; 2007 Aug; 26(8):914-8. PubMed ID: 17697559 [Abstract] [Full Text] [Related]
12. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. Ozsahin M, Belkacémi Y, Pène F, Laporte J, Rio B, Leblond V, Korbas D, Touboul E, Gorin NC, Schlienger M, Laugier A. Int J Radiat Oncol Biol Phys; 1996 Jan 01; 34(1):71-7. PubMed ID: 12118567 [Abstract] [Full Text] [Related]
13. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood. Cohen A, van Lint MT, Uderzo C, Rovelli A, Lavagetto A, Vitale V, Morchio A, Locasciulli A, Bacigalupo A, Romano C. Bone Marrow Transplant; 1995 Mar 01; 15(3):343-8. PubMed ID: 7599557 [Abstract] [Full Text] [Related]
14. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J. Bone Marrow Transplant; 1996 May 01; 17(5):685-9. PubMed ID: 8733682 [Abstract] [Full Text] [Related]
16. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. Gassas A, Sung L, Saunders EF, Doyle JJ. Bone Marrow Transplant; 2006 Dec 01; 38(11):739-43. PubMed ID: 17013424 [Abstract] [Full Text] [Related]
17. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK. Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125 [Abstract] [Full Text] [Related]
18. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Biol Blood Marrow Transplant; 2008 May 01; 14(5):568-75. PubMed ID: 18410899 [Abstract] [Full Text] [Related]
19. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia. Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N. Bone Marrow Transplant; 1998 Jun 01; 21(11):1079-83. PubMed ID: 9645568 [Abstract] [Full Text] [Related]